PN-101
AssetOther
Allogeneic mesenchymal stem cell-derived mitochondria transfer
- Stage
- Phase 2
- Modality
- Other
- Target
- Oxidative phosphorylation
- Indications
- 2
- Trials
- 2
- Developers
- 1
Indications
2Dermatomyositis
Phase 2NOT_YET_RECRUITINGNCT07122648clinicaltrials.gov7 Oct 2026
Polymyositis
Phase 2NOT_YET_RECRUITINGNCT07122648clinicaltrials.gov7 Oct 2026
- Targets and what it contains2
- Owner and partners1
- Trials2
- Evidence for its targets2
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources